Hernexeos
Asset
Inhibits HER2 signaling to suppress growth of HER2-mutant cancer cells.
- Stage
- Stage not known
- Modality
- Small molecule
- Target
- ERBB2
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
0In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors3
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.